Country-of-origin effect of VC investment in biotechnology companies

Journal of Commercial Biotechnology

Volumn 13, Issue 1, 2006, Pages 12-19

  Ang, Siah Hwee ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECH SUBSECTORS; FINANCIAL AND MANAGEMENT RESOURCES;

FINANCE; INDUSTRY; INVESTMENTS; MANAGEMENT;

BIOTECHNOLOGY;

ARTICLE; ASIA; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; CORRELATION ANALYSIS; EUROPE; FINANCIAL MANAGEMENT; GEOGRAPHIC ORIGIN; GERMANY; INVESTMENT; JOINT VENTURE; RESOURCE MANAGEMENT; UNITED KINGDOM; UNITED STATES;

EID: 34447273356     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3050035     Document Type: Article

References (31)

1. Ernst & Young (2005). Annual Global Biotechnology Report-Beyond Borders, Ernst & Young: Ireland.
2. Gompers, P.A. & Lerner, J. (2004). The Venture Capital Cycle, The MIT Press, Cambridge, MA.
3. Finkle, T.A. (1998). The relationships between boards of directors and initial public offerings in the biotechnology. Entrepreneurship: Theory Pract. 22 (3), 5-30.
4. Robbins-Roth, C. (2000). From Alchemy to IPO - The Business of Biotechnology, Perseus Publishing, Cambridge, MA.
5. Stuart, T. & Sorenson, O. (2003). The geography of opportunity: Spatial heterogeneity in founding rates and the performance of biotechnology. Res. Policy 32 (2), 229-253.
6. Wolff, G. (2001). The Biotech Investor's Bible, John Wiley & Sons, New York.
7. Amit, R., Brander, J. & Zott, C. (1998). Why do venture capital firms exist? Theory and Canadian evidence. J. Bus. Venturing 13 (6), 441-467.
8. Fried, V.H. & Hisrich, R.D. (1995). The venture capitalist: A relationship investor. California Manage. Rev. 37 (2), 101-113.
9. Bygrave, W.D. & Timmons, J.A. (1992). Venture Capital at the Crossroads, Harvard Business School Press, Boston, MA.
10. Stuart, T.E., Hoang, H. & Hybels, R. (1999). Interorganizational endorsements and the performance of entrepreneurial ventures. Admin. Sci. Quart. 44 (2), 315-349.
11. Pharr, J.M. (2005). Synthesizing country-of-origin research from the last decade: Is the concept still salient in an era of global brands? J. Marketing Theory Pract. 13 (4), 34-45.
12. Parameswaran, R. & Pisharodi, R.M. (1994). Facets of country of origin image: An empirical assessment. J. Advertising 23 (1), 43-56.
13. Papadopolous, N.G. & Heslop, L.A. (2002). Country equity and country branding: Problems and prospects. J. Brand Manage. 9 (4-5), 294-314.
14. Andersen, P.H. & Chao, P.(2003). Country-oforigin effects in global industrial sourcing: Toward an integrated framework. Manage. Int., Rev. 43 (4), 339-360.
15. Insch, G.S. (2003). The impact of country-of-origin effects on industrial buyers ' perceptions of product quality. Manage. Int. Rev. 43 (3), 219-310.
16. Liang, N. & Parkhe, A. (1997). Importer behavior: The neglected counterpart of international exchange. J. Int. Bus. Stud. 28 (3), 495-530.
17. Han, C.M. & Terpstra, V. (1988). Country-of-origin effects for uni-national and bi-national products. J. Int. Bus. Stud. 19 (2), 235-254.
18. Huber, J. & McCann, J. (1982). The impact of inferential beliefs on product evaluations. J. Marketing Res. 19 (3), 324-333.
19. Han, C.M. (1989). Country image: Halo or summary construct? J. Marketing Res. 26 (2), 222-229.
20. Chao, P. (1993). Partitioning country-of-origin effects: Consumer evaluations. J. Int. Bus. Stud. 24 (2), 291-306.
21. Tyebjee, T.T. & Bruno, A.V. (1984). A model of venture capitalist investment activity. Manage. Sci. 30 (9), 1051-1066.
22. Sorenson, O. & Stuart, T.E. (2001). Syndication networks and spatial distribution of venture capital investments. Am. J. Sociol. 106 (6), 1546-1588.
23. Bygrave, W.D. (1987). Syndicated investments by venture capital fi rms: A networking perspective. J. Bus. Venturing 2 (2), 139-154.
24. Chisik, R. (2002). Reputational comparative advantage and multinational enterprise. Econ. Inq. 40 (4), 582-596.
25. Danzon, P.M., Epstein, A. & Nicholson, S. (2004). Mergers and Acquisitions in the Pharmaceutical and Biotech Industries, National Bureau of Economic Research Working Papers.
26. Saviotti, P., de Looze, M. & Maupertuis, M.A. (2005). Knowledge dynamics, fi rm strategy, mergers and acquisitions in the biotechnology based sectors. Econ. Innov. New Technol. 14 (1-2), 103-124.
27. Reuer, J.J. & Shen, J. (2004). Sequential divestiture through initial public offerings. J. Econ. Behav. Organ. 54 (2), 249-267.
28. Deeds, D., DeCarolis, D. & Coombs, J.E. (1997). The impact of firm-specifi c capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry. J. Bus. Venturing 12 (1), 31-46.
29. Dimov, D.P. & Shepherd, D.A. (2005). Human capital theory and venture capital fi rms: Exploring 'home runs' and 'strike outs'. J. Bus. Venturing 20 (1), 1-22.
30. Lerner, J. (1994). The syndication of venture capital investments. Financ. Manage. 23 (3), 16-28.
31. Shepherd, D.A., Armstrong, M.J. & Lévesque, M. (2005). Allocation of attention within venture capital firms. Eur. J. Opl. Res. 163 (2), 545-565.